Ispire Technology (ISPR) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
20 Jan, 2026Executive summary
Fiscal year 2024 delivered record revenue of $151.9 million, up 31.4% year-over-year, driven by organic growth in the US, Europe, South Africa, and both nicotine and cannabis vaping hardware segments.
Gross profit increased 43.3% to $29.8 million, with gross margin expanding to 19.6% from 18.0%, attributed to product mix, sales leverage, and Malaysian operations.
Net loss widened to $14.8 million, or $0.27 per share, from $6 million, or $0.12 per share, last year, reflecting higher operating expenses supporting global expansion.
Strategic partnerships, global expansion, and a new 31,000 sq. ft. Malaysian facility supported growth and margin improvements.
PMTA application submitted in September 2024, aiming to re-enter the U.S. ENDS market.
Financial highlights
Revenue reached $151.9 million, a 31.4% increase year-over-year; gross profit rose to $29.8 million, up 43.3% year-over-year; gross margin improved to 19.6%.
Net loss widened to $14.8 million, or $0.27 per share, due to higher operating expenses.
Cash and cash equivalents at year-end were $35.1 million; working capital was $16.6 million.
Net cash used in operations was $18.3 million; $10.1 million provided by financing activities.
U.S. product sales increased by $21.5 million to $63.1 million; European sales rose by $6.5 million to $65.3 million; other markets, mainly South Africa, contributed $5.7 million in growth.
Outlook and guidance
No specific revenue guidance for FY2025 due to high uncertainty; growth could range from 30% to 100%.
Majority of growth expected from global nicotine segment, especially through ODM deals and branded products.
Breakeven targeted by fiscal Q3 2025 (March 2025); non-GAAP profitability already achieved in the June quarter.
Plans to capitalize on future growth in both nicotine and cannabis sectors, with continued investment in manufacturing efficiency and technology innovation.
Ongoing efforts to introduce age-verification solutions and responsible marketing to limit underage access to vaping products.
Latest events from Ispire Technology
- FY2025 revenue hit $127.5M, fueled by tech innovation and global expansion.ISPR
Investor presentation13 Feb 2026 - Revenue fell 51.5% but cost controls narrowed losses and set up future growth.ISPR
Q2 20269 Feb 2026 - Gross margin rose to 19.5% as profit improved, but revenue fell and losses widened.ISPR
Q1 202515 Jan 2026 - Shelf registration allows up to $120M in securities to fund growth and innovation in vaping markets.ISPR
Registration Filing16 Dec 2025 - Shareholders will vote on director elections, auditor ratification, and key governance matters.ISPR
Proxy Filing2 Dec 2025 - Gross margin rose to 18.5% on flat revenue, but net loss widened amid global expansion.ISPR
Q2 20251 Dec 2025 - Q3 revenue dropped 12.7% to $26.2M as losses widened and Malaysia shift aims to cut costs.ISPR
Q3 202526 Nov 2025 - Revenue down 22.8% to $30.4M, net loss narrows, and cost controls improve EBITDA.ISPR
Q1 202613 Nov 2025 - Proprietary age-gating tech and Malaysia expansion position the firm for global growth.ISPR
Planet MicroCap Showcase: TORONTO 202522 Oct 2025